Common TitleStudy 110699: Twinrix and Long-Term after Adolescent Immunization
Official Title An Open Multicentre, Multicountry Study to Evaluate Long-term Antibody Persistence and Immune Memory Between Years 11 and 15 After the Primary Study HAB-084 in Which Healthy Adolescents Were Vaccinated With Twinrix™ Adult Following a Two-dose Schedule or Twinrix™ Junior Following a Three-dose Schedule.
Phase Phase IV
ClinicalTrials.gov NCT00875485
Treatments
Twinrix
Twinrix
Tradename:TwinrixClass:Vaccines (HBV)Funding
IndustryGlaxoSmithKline